来自 2021 年和 2022 年全国橄榄球联盟处方药监控计划的疼痛用药数据。

IF 1.7 4区 医学 Q3 SPORT SCIENCES
Kevin P Hill, Kurt Kroenke, Erin B Wasserman, Christina Mack, Geoffrey S F Ling, Thom Mayer, Gary S Solomon, Allen Sills
{"title":"来自 2021 年和 2022 年全国橄榄球联盟处方药监控计划的疼痛用药数据。","authors":"Kevin P Hill, Kurt Kroenke, Erin B Wasserman, Christina Mack, Geoffrey S F Ling, Thom Mayer, Gary S Solomon, Allen Sills","doi":"10.1249/JSR.0000000000001200","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>We report 2021 and 2022 prescription drug monitoring program data that include pain medication prescriptions, including over-the-counter medications, issued to NFL players by either club physicians or external medical providers and entered in the NFL electronic medical record. Of 3142 players who signed a contract with at least one NFL Club during the 2021 season, there were 14,903 prescriptions for pain medications issued to 2207 players. During the 2022 season, there were 14,880 prescription pain medications issued to 2189 players (out of a population of 3152). Notably, most pain medication prescriptions across the two seasons were for nonsteroidal anti-inflammatory agents (NSAIDs; 85.1%), whereas only 2.9% were for opioids. Despite the demanding physical nature of professional football and the need for pain management during a season, the prevalence of opioid prescriptions among NFL players appears to be similar to and, in some cases, potentially lower than previous U.S. population-based data.</p>","PeriodicalId":10922,"journal":{"name":"Current sports medicine reports","volume":"23 10","pages":"348-351"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pain Medication Data from the 2021 and 2022 National Football League Prescription Drug Monitoring Program.\",\"authors\":\"Kevin P Hill, Kurt Kroenke, Erin B Wasserman, Christina Mack, Geoffrey S F Ling, Thom Mayer, Gary S Solomon, Allen Sills\",\"doi\":\"10.1249/JSR.0000000000001200\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Abstract: </strong>We report 2021 and 2022 prescription drug monitoring program data that include pain medication prescriptions, including over-the-counter medications, issued to NFL players by either club physicians or external medical providers and entered in the NFL electronic medical record. Of 3142 players who signed a contract with at least one NFL Club during the 2021 season, there were 14,903 prescriptions for pain medications issued to 2207 players. During the 2022 season, there were 14,880 prescription pain medications issued to 2189 players (out of a population of 3152). Notably, most pain medication prescriptions across the two seasons were for nonsteroidal anti-inflammatory agents (NSAIDs; 85.1%), whereas only 2.9% were for opioids. Despite the demanding physical nature of professional football and the need for pain management during a season, the prevalence of opioid prescriptions among NFL players appears to be similar to and, in some cases, potentially lower than previous U.S. population-based data.</p>\",\"PeriodicalId\":10922,\"journal\":{\"name\":\"Current sports medicine reports\",\"volume\":\"23 10\",\"pages\":\"348-351\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current sports medicine reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1249/JSR.0000000000001200\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"SPORT SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current sports medicine reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1249/JSR.0000000000001200","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SPORT SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

摘要:我们报告了 2021 年和 2022 年处方药监控项目的数据,其中包括由俱乐部医生或外部医疗提供者开给 NFL 球员并输入 NFL 电子病历的止痛药处方,包括非处方药。在 2021 赛季与至少一家 NFL 俱乐部签约的 3142 名球员中,有 2207 名球员获得了 14903 张止痛药处方。在 2022 赛季,2189 名球员(总人数为 3152 人)共收到 14880 份止痛药处方。值得注意的是,在这两个赛季中,大多数止痛药处方都是非类固醇消炎药(NSAIDs,85.1%),而阿片类药物仅占 2.9%。尽管职业橄榄球运动对体力要求很高,而且在一个赛季中需要进行疼痛治疗,但 NFL 球员中阿片类药物处方的流行率似乎与之前基于美国人口的数据相似,在某些情况下甚至可能更低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pain Medication Data from the 2021 and 2022 National Football League Prescription Drug Monitoring Program.

Abstract: We report 2021 and 2022 prescription drug monitoring program data that include pain medication prescriptions, including over-the-counter medications, issued to NFL players by either club physicians or external medical providers and entered in the NFL electronic medical record. Of 3142 players who signed a contract with at least one NFL Club during the 2021 season, there were 14,903 prescriptions for pain medications issued to 2207 players. During the 2022 season, there were 14,880 prescription pain medications issued to 2189 players (out of a population of 3152). Notably, most pain medication prescriptions across the two seasons were for nonsteroidal anti-inflammatory agents (NSAIDs; 85.1%), whereas only 2.9% were for opioids. Despite the demanding physical nature of professional football and the need for pain management during a season, the prevalence of opioid prescriptions among NFL players appears to be similar to and, in some cases, potentially lower than previous U.S. population-based data.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.00
自引率
5.60%
发文量
150
审稿时长
>12 weeks
期刊介绍: As an official clinical journal of the American College of Sports Medicine (ACSM), Current Sports Medicine Reports is unique in its focus entirely on the clinical aspects of sports medicine. This peer-reviewed journal harnesses the tremendous scientific and clinical resources of ACSM to develop articles reviewing recent and important advances in the field that have clinical relevance. The journal’s goal is to translate the latest research and advances in the field into information physicians can use in caring for their patients. To accomplish this goal, the journal divides the broad field of sports medicine into 12 sections, each headed by a physician editor with extensive practical experience in that area. The current sections include: Head, Neck, and Spine - General Medical Conditions - Chest and Abdominal Conditions - Environmental Conditions - Sideline and Event Management - Training, Prevention, and Rehabilitation - Exercise is Medicine- Nutrition & Ergogenic Aids - Extremity and Joint Conditions - Sport-specific Illness and Injury - Competitive Sports - Special Populations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信